Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents
US5435998A · kind A · utility
22Cited by
3References
26Claims
0Family size
Inventor
Key dates
| Filing date | Aug 3, 1994 |
| Grant date | Jul 25, 1995 |
| Priority date | — |
| Expiry date | Aug 3, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Low-tension glaucoma is treated by topical administration to the eye of an amount of a calcium channel blocking agent effective to increase blood flow to the optic nerve head. Calcium channel blocking agents of Class I are especially useful, and among these a preferred agent is verapamil hydrochloride.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.